General Dermatology
General Dermatology Services Q & A What are general dermatology services? Dr. Brown provides general dermatology services for the diagnosis and treatment of skin conditions
QWO® (Cellulite Treatment)
The injection targets the bands beneath the skin surface resulting in the smoothing of the skin to improve the appearance of cellulite.
AVERAGE RATING
★★★★★ 0.0/5
0 Review(s)
Score: 0.0
{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
Table of Contents
Services
SculpSure
When you go in for your SculpSure appointment, Dr. Brown uses a gentle handheld device to go over all of your problem areas.
DermaFirm
Dermaplane followed with an Ageless Stem Cell & Peptide Mask.
Platelet Rich Plasma
Platelet-rich plasma (PRP) is a substance that is derived from your own blood.
Chemical Peels
Your health is your most important asset. You should entrust it only to the best professionals.
Skin Cancer Screening
The examination of your skin to detect suspicious spots that could be cancerous.
QWO® injections are a minimally invasive cosmetic procedure that goes below the surface of the skin to address the causes of cellulite. The injection targets the bands beneath the skin surface resulting in the smoothing of the skin to improve the appearance of cellulite.
Q&A
What is QWO®?
- QWO® is a prescription medicine used to treat moderate to severe cellulite in the buttocks of adult women.
Can you share some before and after images of QWO® patients?
- Below are before and after images of two QWO® patients. Each patient received three treatments 21-days apart.
Actual patients. Individual results may vary. Unretouched photos were taken before QWO and 28 days after the final treatment.
How many treatments are there?
- There are three QWO® treatments –one every 3 weeks.
Do I need to expect any downtime after my treatment?
- In clinical trials, no post-treatment downtime was required. However, individual results may vary.
What is cellulite?
- Cellulite is a localized alteration in the contour of the skin that has been reported in approximately 90% of adult women of all races and ethnicities.
What causes cellulite?
- Over time, three completely normal things can happen. Fat cells get larger, skin gets thinner and a little looser, and the fibrous bands under the skin’s surface get thicker, leading to a dimpled appearance.
Who gets cellulite?
- Women are more likely to have cellulite than men, and it affects women of all shapes, sizes, ages, and races.
Why aren’t men prone to developing cellulite?
- Men have thicker skin than women do, and their collagen bands are oriented in a crisscross fashion, essentially eliminating the ability of the fat lobules to bulge through. If a man is given estrogen hormones (as in some cancer treatments), they can develop cellulite if there is enough fat.
Are fat and cellulite the same?
- Fat is not cellulite and does not cause it, but fat cells getting bigger between fibrous bands under the skin can contribute to a bumpy appearance.
What are the side-effects of QWO?
- The most common side-effects of QWO include injection site bruising, pain, areas of hardness, itching, redness, discoloration, swelling, and warmth in the treatment area. In clinical studies, side effects generally lasted less than three weeks.
INDICATION AND IMPORTANT SAFETY INFORMATION FOR Qwo® (collagenase clostridium histolyticum-aaes)
INDICATION
QWO® is indicated for the treatment of moderate to severe cellulite in the buttocks of adult women.
IMPORTANT SAFETY INFORMATION FOR QWO
CONTRAINDICATIONS
QWO® is contraindicated in patients with a history of hypersensitivity to collagenase or to any of the excipients or the presence of infection at the injection sites.
WARNINGS AND PRECAUTIONS
Hypersensitivity Reactions
Serious hypersensitivity reactions including anaphylaxis have been reported with the use of collagenase clostridium histolyticum. If such a reaction occurs, further injection of QWO should be discontinued and appropriate medical therapy immediately instituted. Advise patients to seek immediate medical attention if they experience any symptoms of serious hypersensitivity reactions.
Injection Site Bruising
In clinical trials, 84% of subjects treated with QWO experienced injection site bruising. Subjects with coagulation disorders or using anticoagulant or antiplatelet medications (except those taking ≤150 mg aspirin daily) were excluded from participating in Trials 1 and 2.
QWO should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet (except those taking ≤150 mg aspirin daily) or anticoagulant therapy.
Substitution of Collagenase Products
QWO must not be substituted with other injectable collagenase products.
QWO is not intended for the treatment of Peyronie’s Disease or Dupuytren’s Contracture.
ADVERSE REACTIONS
In clinical trials, the most commonly reported adverse reactions in patients treated with QWO with an incidence ≥ 10% were at the injection site: bruising, pain, nodule, and pruritus.
